Author:
Weerink Maud A. S.,Struys Michel M. R. F.,Hannivoort Laura N.,Barends Clemens R. M.,Absalom Anthony R.,Colin Pieter
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference145 articles.
1. Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology. 1992;77:1125–33.
2. US Food and Drug Administration. Precedex label. 1999. Available from:
http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/21038lbl.pdf
. Accessed 14 Nov 2016.
3. European Medicines Agency. European Public Assessment Report. 2016. Available from:
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002268/WC500115631.pdf
. Accessed 14 Nov 2016.
4. Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol. 1988;150:9–14.
5. Guo TZ, Tinklenberg J, Oliker R, Maze M. Central alpha 1-adrenoceptor stimulation functionally antagonizes the hypnotic response to dexmedetomidine, an alpha 2-adrenoceptor agonist. Anesthesiology. 1991;75:252–6.
Cited by
724 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献